2-Methoxyestradiol (2-ME) has been proved to be able to elevate ROS level in tumor sites by inhibiting superoxide dismutase (SOD) 10, which is beneficial to cause oxidative stress and accelerate the release of parent CPT from the prodrug TK-CPT. This evidence concerns the gene SOD1 and neoplasm.